2024-01-01 2024-12-31 false No description of principal activity Capium Accounts Production 1.1 06036579 2024-01-01 2024-12-31 06036579 bus:AbridgedAccounts 2024-01-01 2024-12-31 06036579 bus:FRS102 2024-01-01 2024-12-31 06036579 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 06036579 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 06036579 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 06036579 2024-01-01 2024-12-31 06036579 2024-12-31 06036579 bus:RegisteredOffice 2024-01-01 2024-12-31 06036579 core:WithinOneYear 2024-12-31 06036579 core:AfterOneYear 2024-12-31 06036579 1 2024-01-01 2024-12-31 06036579 bus:Director1 2024-01-01 2024-12-31 06036579 bus:Director1 2024-12-31 06036579 bus:Director1 2023-01-01 2023-12-31 06036579 2023-01-01 06036579 bus:CompanySecretary1 2024-01-01 2024-12-31 06036579 bus:LeadAgentIfApplicable 2024-01-01 2024-12-31 06036579 2023-01-01 2023-12-31 06036579 2023-12-31 06036579 core:WithinOneYear 2023-12-31 06036579 core:AfterOneYear 2023-12-31 06036579 bus:EntityAccountantsOrAuditors 2023-01-01 2023-12-31 06036579 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 06036579 bus:OrdinaryShareClass1 2024-12-31 06036579 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 06036579 bus:OrdinaryShareClass1 2023-12-31 06036579 core:ComputerEquipment 2024-01-01 2024-12-31 06036579 core:ComputerEquipment 2024-12-31 06036579 core:ComputerEquipment 2023-12-31 06036579 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-12-31 06036579 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2023-12-31 06036579 core:CostValuation core:Non-currentFinancialInstruments 2024-12-31 06036579 core:CostValuation core:Non-currentFinancialInstruments 2023-12-31 06036579 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-12-31 06036579 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 06036579 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-12-31 06036579 core:Non-currentFinancialInstruments 2024-12-31 06036579 core:Non-currentFinancialInstruments 2023-12-31 06036579 core:ShareCapital 2024-12-31 06036579 core:ShareCapital 2023-12-31 06036579 core:RetainedEarningsAccumulatedLosses 2024-12-31 06036579 core:RetainedEarningsAccumulatedLosses 2023-12-31 06036579 dpl:Item1 2024-01-01 06036579 dpl:Item1 2024-12-31 06036579 dpl:Item1 2023-01-01 06036579 dpl:Item1 2023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 06036579
England and Wales

 

 

 

SAFEGUARD BIOSYSTEMS MANUFACTURING LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 January 2024

End date: 31 December 2024
 
 
Notes
 
2024
£
  2023
£
Fixed assets      
Tangible fixed assets 3 6,899   
6,899   
Current assets      
Debtors 876    3,764 
Cash at bank and in hand 19,031    15,336 
19,907    19,100 
Creditors: amount falling due within one year (1,847,348)   (1,285,550)
Net current assets (1,827,441)   (1,266,450)
 
Total assets less current liabilities (1,820,542)   (1,266,450)
Provisions for liabilities (1,725)  
Net assets (1,822,267)   (1,266,450)
 

Capital and reserves
     
Called up share capital 4 10    10 
Profit and loss account (1,822,277)   (1,266,460)
Shareholders' funds (1,822,267)   (1,266,450)
 


For the year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 29 September 2025 and were signed by:


-------------------------------
Howard Sherman
Director
1
General Information
Safeguard Biosystems Manufacturing Limited is a private company, limited by shares, registered in England and Wales, registration number 06036579, registration address Quadrant House Floor 6, 4 Thomas More Square, London, E1W 1YW.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Going concern basis
The company did not  generate income for the year ended 31st December 2024 and had a loss for the year of £551,002 (2023: £503,869).
The financial statements have beeen prepared on a going concern basis notwithstanding the unfavourable financial results.
Turnover
Turnover is measured at the fair value of the consideration received or receivable net of VAT and trade discounts. Turnover includes revenue earned from the sale of goods and from the rendering of service, the policies adopted are as follows:

Sale of goods
Sale of goods revenue is recognised at the point of sale, which is usually where the customer has taken delivery of the goods, the risks and rewards are transferred to the customer and there is a valid sales contract. Amounts disclosed as revenue are net of sales returns and trade discounts.

Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

Other revenue
Other revenue is recognised when it is received or when the right to receive payment is established.
Research and development expenditure
Research and development expenditure is charged to the income statement in the period in which it is incurred.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Deferred taxation
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the reporting date.
Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 33% Reducing Balance
Provisions
Provisions are recognised when the company has a present obligation as a result of a past event which it is more probable than not will result in an outflow of economic benefits that can be reasonably estimated.
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.

Average number of employees

Average number of employees during the year was 7 (2023 : 7).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 January 2024  
Additions 7,527    7,527 
Disposals  
At 31 December 2024 7,527    7,527 
Depreciation
At 01 January 2024  
Charge for year 628    628 
On disposals  
At 31 December 2024 628    628 
Net book values
Closing balance as at 31 December 2024 6,899    6,899 
Opening balance as at 01 January 2024  


4.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
1,000 Ordinary shares of £0.01 each 10    10 
10    10 

5.

Parent Company

The company is a wholly owned subsidiary of Safeguard DX limited, a company incorporated and registered in England and Wales.
2